ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1483

A Randomised Controlled Trial Evaluating the Efficacy of Internet-based Exercises Aimed at Treating Knee Osteoarthritis (iBEAT-OA)

Sameer Gohir1, Abhishek Abhishek2, Anthony Kelly2 and Ana M Valdes3, 1NIHR Nottingham Biomedical Research Centre, GRAYS ESSEX, England, United Kingdom, 2University of Nottingham, Nottingham, United Kingdom, 3NIHR Nottingham Biomedical Research Centre, School of Medicine, University of Nottingham, Nottingham, England, United Kingdom

Meeting: ACR Convergence 2020

Keywords: Aging, exercise, Osteoarthritis, Randomized Trial

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 8, 2020

Title: Osteoarthritis I: Clinical Trials (1482–1486)

Session Type: Abstract Session

Session Time: 4:00PM-4:50PM

Background/Purpose: Osteoarthritis (OA) is the commonest cause of pain and disability in the general population and is usually managed by family doctors and physiotherapists. This study aimed to explore the benefits of digital delivery of exercises on pain, function, and other health-related outcomes in individuals with painful knee OA.

Methods: iBEAT-OA was a primary-care based randomised controlled trial in which participants with knee OA were 1:1 randomised to web-based exercises or usual care. The study was designed to ascertain whether, after 6 weeks, i-BEAT-OA was more effective to reduce the pain than continued usual care. The eligibility criteria are shown in Figure 1.

An app-based exercises platform known as Joint Academy (JA) was used as an intervention given to treatment arm. There were two face-to-face sessions with a physiotherapist for both arms, at enrolment and six weeks. Visual Analogue Score (VAS), Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), The Arthritis Research UK Musculoskeletal Health Questionnaire (MSK-HQ), Pittsburgh Sleep Quality Index (PSQI),  30-second sit to stand test (30CST), Time up and go test (TUG), Quantitative Sensory Testing (QST), Maximum Voluntary Contraction (MVC)- isokinetic contraction of Quadriceps / Hamstring muscle, urine and blood samples were taken at baseline and at six weeks follow up. Participants were given an actigraphy device.

We compared groups at baseline and after 6 weeks by intention to treat.

The primary outcome was the change in pain (mean difference) assessed by visual analogue scores (VAS) between baseline and follow-up between the treatment and control arms. The difference within arms between baseline and follow-up was assessed using a paired t-test. A similar model was used for other variables. Regression analysis models were used to assess confounding factors. The threshold for statistical significance was set at level .05 with 2-sided testing.

Results: The recruitment was stopped in March 2020 due to COVID-19 lockdown instructions.  In total, 105 participants (48 participants in the intervention arm and 57 participants in the control arm) had completed data for both baseline and follow-up assessments. No significant differences in baseline characteristics were seen (Table 1).

The mean difference in pain as measured by a visual analogue scale (0-10) from baseline minus follow-up for the treatment arm was a drop of -1.79 [95%CI -1.16 to -2.41], for the control arm it was -0.39 [95%CI -0.97 to 0.18]. The mean difference between the treatment and control arms was 1.39 [95%CI 0.55-2.2] p< 0.0014 favouring the treatment arm.

Conclusion: Among participants with knee pain from OA, use of the Joint Academy app compared with control group resulted in an improvement in pain, function and muscle strength at 6 weeks follow-up that was statistically significant. Furthermore, there was improved muscle strength of hamstring and functional activities in intervention group. With COVID-19 pandemic, when social distancing is a vital prerequisite of staying safe, apps such as Joint Academy can be useful tools to manage knee OA at home.

Figure 1: Inclusion and Exclusion Criteria for iBEAT-OA trial

Table 1: Baseline Characteristics


Disclosure: S. Gohir, None; A. Abhishek, None; A. Kelly, None; A. Valdes, None.

To cite this abstract in AMA style:

Gohir S, Abhishek A, Kelly A, Valdes A. A Randomised Controlled Trial Evaluating the Efficacy of Internet-based Exercises Aimed at Treating Knee Osteoarthritis (iBEAT-OA) [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/a-randomised-controlled-trial-evaluating-the-efficacy-of-internet-based-exercises-aimed-at-treating-knee-osteoarthritis-ibeat-oa/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-randomised-controlled-trial-evaluating-the-efficacy-of-internet-based-exercises-aimed-at-treating-knee-osteoarthritis-ibeat-oa/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology